Advanced Regenerative Bio Act Amendments and the Korean Clinical Trial Environment: A Practical Guide
1. Background and goals The amended Advanced Regenerative Bio Act, effective 21 February 2025, marks a policy turnaround by expanding access to advanced regenerative medicine and strengthening patient‑safety management. The law lifts research‑subject restrictions so that therapies can be provided…